Article Information
History
- September 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- JGF Gilmer, PhD, Research Director, Head of School1,2,
- Fiona Ryan, PhD, Director of Clinical Trials2,
- Anna Seoighe, MSc, Research Pharmacist1,
- Maria Jose Santos-Martinez, MD, Associate Professor, Clinical Medicine1,
- Cristin Ryan, PhD, Professor of Pharmacy Practice1 and
- Mark Ledwidge, PhD, Research and Development Director, Adjunct Professor1,2,3,*
- 1School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland
- 2Solvotrin Therapeutics, Little Island, Cork, Ireland
- 3School of Medicine, University College Dublin, Ireland
- ↵*Corresponding Author:
Prof. Mark Ledwidge, Email:
mark.ledwidge{at}ucd.ie, Telephone:
+353-1-2845735, Fax:
+353-1-2304639
Authors contributions: JG and ML developed the hypothesis, obtained the data, analysed the data and wrote the manuscript. FR obtained the data and contributed to the writing of the manuscript.